📰 B Pfizer News
Page 8 - B Pfizer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from B Pfizer. Real-time updates on events, politics, business and more.
November 3, 2021
The Centers for Disease Control and Prevention signed off Tuesday on giving a COVID-19 vaccine to kids ages 5 to 11, clearing the way for the pediatric vaccination drive to kick off within days.
November 2, 2021
The Centers for Disease Control and Prevention signed off Tuesday on giving a COVID-19 vaccine to kids ages 5 to 11, clearing the way for the pediatric vaccination drive to kick off within days.
October 30, 2021
Vice President Kamala Harris received a third dose of the Moderna COVID-19 vaccine on Saturday as the booster program expands to millions more Americans.
October 30, 2021
Vice President Kamala Harris received a third dose of the Moderna COVID-19 vaccine on Saturday as the booster program expands to millions more Americans.
October 28, 2021
Fewer than a third of parents plan to vaccinate their children for COVID-19 "right away" once the shots become available to 5- to 11-year-olds, according to a poll released Thursday.
October 28, 2021
Fewer than a third of parents plan to vaccinate their children for COVID-19 "right away" once the shots become available to 5- to 11-year-olds, according to a poll released Thursday.
October 26, 2021
Advisers to the Food and Drug Administration are debating Tuesday whether to recommend the COVID-19 vaccine from Pfizer-BioTech for emergency use in 5- to 11-year-olds, setting the stage for shots to become available to 28 million school-aged children by the start of November.
October 26, 2021
Advisers to the Food and Drug Administration are debating Tuesday whether to recommend the COVID-19 vaccine from Pfizer-BioTech for emergency use in 5- to 11-year-olds, setting the stage for shots to become available to 28 million school-aged children by the start of November.
October 26, 2021
A key advisory panel on Tuesday recommended the Pfizer-BioNTech COVID-19 shots for emergency use in children ages 5 to 11, setting the stage for shots to become available to 28 million children by early November and fueling debate over the risks and rewards of vaccinating an age group that's accounted for 0.01% of COVID-19 deaths in America.
October 26, 2021
A key advisory panel on Tuesday recommended the Pfizer-BioNTech COVID-19 shots for emergency use in children ages 5 to 11, setting the stage for shots to become available to 28 million children by early November and fueling debate over the risks and rewards of vaccinating an age group that's accounted for 0.01% of COVID-19 deaths in America.